Dengue virus (DENV) causes frequent epidemics infecting ϳ390 million people annually in over 100 countries. There are no approved vaccines or antiviral drugs for treatment of infected patients. However, there is a novel approach to control DENV transmission by the mosquito vectors, Aedes aegypti and Aedes albopictus, using the Wolbachia symbiont. The wMelPop strain of Wolbachia suppresses DENV transmission and shortens the mosquito life span. However, the underlying mechanism is poorly understood. To clarify this mechanism, either naive A. albopictus (C6/ 36) or wMelPop-C6/36 cells were infected with DENV serotype 2 (DENV2). Analysis of host transcript profiles by transcriptome sequencing (RNAseq) revealed that the presence of wMelPop dramatically altered the mosquito host cell transcription in response to DENV2 infection. The viral RNA evolved from wMelPop-C6/36 cells contained low-frequency mutations (ϳ25%) within the coding region of transmembrane domain 1 (TMD1) of E protein. Mutations with Ͼ97% frequencies were distributed within other regions of E, the NS5 RNA-dependent RNA polymerase (NS5POL) domain, and the TMDs of NS2A, NS2B, and NS4B. Moreover, while DENV2-infected naive C6/36 cells showed syncytium formation, DENV2-infected wMelPop-C6/36 cells did not. The Wolbachia-induced mutant DENV2 can readily infect and replicate in naive C6/36 cells, whereas in mutant DENV2-infected BHK-21 or Vero cells, virus replication was delayed. In LLC-MK2 cells, the mutant failed to produce plaques. Additionally, in BHK-21 cells, many mutations in the viral genome reverted to the wild type (WT) and compensatory mutations in NS3 gene appeared. Our results indicate that wMelPop impacts significantly the interactions of DENV2 with mosquito and mammalian host cells. IMPORTANCE Mosquito-borne diseases are of global significance causing considerable morbidity and mortality throughout the world. Dengue virus (DENV; serotypes 1 to 4), a member of the Flavivirus genus of the Flaviviridae family, causes millions of infections annually. Development of a safe vaccine is hampered due to absence of cross-protection and increased risk in secondary infections due to antibody-mediated immune enhancement. Infection of vector mosquitoes with Wolbachia bacteria offers a novel countermeasure to suppress DENV transmission, but the mechanisms are poorly understood. In this study, the host transcription profiles and viral RNA sequences were analyzed in naive A. albopictus (C6/36) and wMelPop-C6/36 cells by RNAseq. Our results showed that the wMelPop symbiont caused profound changes in host transcription profiles and morphology of DENV2-infected C6/36 cells. Accumulation of several mutations throughout DENV2 RNA resulted in loss of infectivity of progeny virions. Our findings offer new insights into the mechanism of Wolbachiamediated suppression of DENV transmission.
T he four serotypes of dengue virus (DENV1 to -4), members of the Flavivirus genus in the Flaviviridae family, are transmitted by Aedes aegypti and Aedes albopictus mosquitoes. These mosquito species are prevalent throughout tropical and subtropical regions of the world. The disease burden caused by DENV1 to -4 has been estimated at ϳ390 million infections annually, of which 20% to 30% are symptomatic with high fever and flu-like symptoms. The symptomatic DENV infections caused by any one serotype resolve in 7 to 10 days and confer lifelong immunity against that serotype. However, some cases could progress to severe dengue, especially in secondary infections by a different serotype, leading to ϳ25,000 deaths annually (1) . There are no FDA-approved vaccines or antiviral drugs available for prevention or treatment of dengue cases.
The DENV genome is a single-stranded, positive-sense RNA of ϳ11 kb in length, and it encodes a single open reading frame (ORF) flanked by 5= and 3= untranslated regions (UTR) with a type 1 cap at the 5= end without a poly(A) tail at the 3= end (2, 3) . The viral RNA is translated in the endoplasmic reticulum (ER) by the host machinery to yield a polyprotein precursor. Processing of the precursor into mature proteins is carried out by both cellular and viral proteases into three structural proteins (capsid [C], precursor membrane [prM] , and envelope [E]) and seven nonstructural (NS) proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) (2) . NS1 to NS5 proteins together with unknown host proteins form the replication complex (RC) in the ER membrane and are involved in the viral replication process.
NS3 and NS5 are cytosolic proteins. NS3 interacts with the ER-resident hydrophobic integral membrane protein, NS2B (4-8; reviewed in references 2 and 9) and forms an active serine protease (NS2B-NS3pro). The viral protease in conjunction with the ER resident cellular proteases is involved in the processing of the polyprotein precursor into mature proteins prior to viral replication and viral assembly (10) . The C-terminal region of NS3 exhibits ATP-dependent RNA helicase and 5= RNA triphosphatase activities which are involved in viral replication (11) (12) (13) and in the first step in 5= RNA capping (14, 15) .
NS5 also plays important roles in viral replication and 5= RNA capping (reviewed in reference 16) . The N-terminal region of NS5 has the guanylyltransferase, the N-7 and 2=-O-methyltransferase activities (17) (18) (19) that are essential for the formation of type 1 cap at the 5= end. The C-terminal region of NS5 codes for RNA-dependent RNA polymerase activity involved in RNA replication (10, (20) (21) (22) . NS2A, NS2B, NS4A, and NS4B contain transmembrane domains (TMDs) that penetrate the ER. NS2A has five TMDs and is indispensable for viral RNA synthesis as well as virion assembly (23) (24) (25) . NS2B has three TMDs; one is located at the N terminus, and two are at the C terminus of NS2B (8, 26, 27 ; reviewed in reference 9). TMDs in NS2B contribute to both viral RNA replication and virion assembly (10) . In addition, two TMDs also exist in E protein that are essential for virion assembly in the ER (28) .
Strategies have recently been developed for reducing DENV transmission by mosquito vector populations by releasing the mosquitoes infected with the bacterial endosymbiont Wolbachia, such as wMelPop strain (29) (30) (31) . wMelPop causes cytoplasmic incompatibility (CI) resulting in no offspring when infected male mosquitoes (with the exception of the wAu strain of Wolbachia, which does not induce CI [32] ) mate with uninfected females or females infected with a different strain of Wolbachia (33, 34) . Therefore, uninfected females are at a reproductive disadvantage relative to infected females once a Wolbachia infection has entered a population. This reproductive fitness asymmetry can lead to rapid spread of Wolbachia infection through natural populations (35) . wMelPop also shortens the life span of A. aegypti by 50% and interferes with transmission of mosquito-borne viruses, including DENV, West Nile virus (WNV), and Chikungunya virus (CHIKV), as well as malarial parasite (36) (37) (38) (39) . Previous work indicated that the Wolbachia-mediated suppression of DENV transmission is due to "immune priming" by inducing reactive oxygen species (ROS)-dependent activation of the Toll pathway in Aedes aegypti (40, 41) . However, it remains unclear as to whether additional mechanisms contribute to the suppression of DENV transmission by Aedes mosquito vectors.
In this study, we examined the mechanism of wMelPop-mediated suppression of DENV infection using the A. albopictus (C6/36) cells. We focused on analyses of the effects of wMelPop infection of host C6/36 cells on the DENV2 genome, a topic that has not received previous attention. We describe the morphological changes, infectivity (as determined by plaque assay), RNA replication (as determined by quantitative reverse transcriptase PCR [qRT-PCR]), and mosquito cellular transcriptomic analysis of naive C6/36 versus wMelPop-C6/36 cells as summarized in Fig. 1 . Our results indicate that the infection of wMelPop-C6/36 cells with DENV2 abolished syncytium formation, which is the hallmark of normal C6/36 cells infected with DENV1 to -4, Japanese encephalitis virus (JEV), and yellow fever virus (YFV) (42) . Furthermore, we showed by transcriptome sequencing (RNAseq) that wMelPop infection of C6/36 cells dramatically altered the transcriptional response to DENV2 infection and that DENV2 RNA acquired adaptive mutations during replication in wMelPop-C6/36 cells. We found that replication of mutant DENV2 was suppressed significantly in two mammalian cell types, BHK-21 and Vero, in contrast to naive C6/36 cells. Our results provide new insight into mechanistic interactions between the wMelPop strain of Wolbachia, C6/36 mosquito cells, and DENV2 infection.
RESULTS

DENV2 infection does not induce syncytium formation in wMelPop-C6/36 cells.
Before we analyzed the host cell responses of DENV2 infection in naive C6/36 cells and wMelPop-C6/36 cells, we first verified that wMelPop-C6/36 cells do harbor the symbiont by PCR using C6/36-and wMelPop-specific primers as described in Materials and Methods. C6/36-specific primers from the ND5 gene detected a 199-bp fragment in DNA from both cell types (Fig. 2, lanes 1 and 2) , whereas the wMelPop-specific IS5 gene primers detected the 201-bp fragment only in DNA from the wMelPop-C6/36 cells (Fig.  2, lane 4) . We also examined differences in host cell morphology of naive C6/36 and wMelPop-C6/36 cells infected with DENV2. Polykaryons (syncytia or cell fusion) are well-known morphological modifications of C6/36 cells induced by DENV1 to DENV4, JEV, and YFV (42) (43) (44) . This property was attributed to E protein, as it was blocked by an anti-E monoclonal antibody but not by antibodies against prM or NS1 (42). We infected naive C6/36 or wMelPop-C6/36 cells with DENV2 at a multiplicity of infection (MOI) of 1. Syncytia appeared and spread in naive C6/36 cells at 3 days postinfection ( Fig. 3A , left, top and bottom) whereas syncytia were not observed in wMelPop-C6/36 cells even at 5 days postinfection ( Fig. 3A , right, top and bottom).
Analysis of DENV2 infectivity by plaque assay and viral RNA copy number by qRT-PCR. Supernatants from naive C6/36 cells or wMelPop-C6/36 cells infected with DENV2 were tested for the presence of infectious virus particles by plaque assay performed in LLC/MK2 (monkey kidney) cells as described previously (45) . As shown in Fig. 3B , no plaques were detected in LLC-MK2 cells when the supernatants from DENV2-infected wMelPop-C6/36 cells were used (Fig. 3B, bottom) . In contrast, abundant plaques (2 ϫ 10 5 to 3 ϫ 10 5 PFU/ml) were formed when the supernatants from DENV2-infected naive C6/36 cells were used ( Fig. 3B, top) . On the other hand, the qRT-PCR analysis of DENV2 RNA copy number showed that there was no significant difference between the DENV2-infected naive C6/36 and the wMelPop-C6/36 cells under the same experimental conditions ( Fig. 3C ). Expression of the cellular gene jun was used as a control ( Fig. 3C ) for comparison of cell extracts of naive C6/36 and wMelPop-C6/36 cells. The results show that DENV2 is able to replicate in both naive C6/36 and wMelPop-C6/36 cells but produces infectious progeny virus only in naive C6/36 cells. C6/36 host gene expression in response to DENV2 infection is modulated by Wolbachia. Next, we sought to analyze the gene expression of naive C6/36 and wMelPop-C6/36 cells in response to DENV2 infection by RNAseq. We prepared total RNA samples from four different experimental conditions that included 11 biological replicates as described in Materials and Methods (Table 1) . We first used a multidimensional scaling plot to examine the normalized RNAseq gene expression values. As shown in Fig. 4 , the four different experimental treatments exhibited distinct gene expression profiles, as indicated by clustering of biological replicates from the same treatment. These results show that naive C6/36 cells infected with DENV2 (solid circles in This trend is further supported by comparing the numbers of transcripts either significantly upregulated or downregulated (Ͼ4ϫ and 8ϫ). When wMelPop-C6/36 versus naive C6/36 cells were compared, we observed that almost equal numbers of transcripts were upregulated and downregulated Ͼ4ϫ (521 and 451, respectively). On the other hand, when DENV2-infected naive C6/36 cells were compared to naive C6/36 cells, it was found that 1,202 genes were upregulated and 168 genes were downregulated Ͼ4ϫ. This trend was dramatically reversed when DENV2-infected wMelPop-C6/36 cells were compared with DENV2-infected naive C6/36 cells: 348 genes were upregulated Ͼ4ϫ and 1,144 genes were downregulated Ͼ4ϫ. These data corroborate the results shown in Fig. 5 .
Furthermore, we observed that 510 genes were upregulated Ͼ8ϫ in DENV2infected naive C6/36 cells and 605 genes were downregulated Ͼ8ϫ in DENV2-infected wMelPop-C6/36 cells. Among these, we identified 319 common transcripts. Of these, we were able to identify 96 functionally annotated genes using VectorBase (https:// www.vectorbase.org) ( Table 2) . From this list, we chose 6 genes that are involved in cholesterol/lipid metabolism of DENV-infected mammalian and/or mosquito cells (46) (47) (48) (49) (50) for which functional annotations and documented effects on DENV life cycle Fig. 3 ). However, viral RNA copy numbers remain essentially the same in naive versus wMelPop-C6/36 cells. Therefore, we investigated whether any mutation(s) appeared in the viral RNA under the altered cellular environment in wMelPop-C6/36 cells that could affect the ability of the virus to form plaques. This possibility has not been reported previously as a mechanism for why wMelPop causes suppression of DENV infectivity. We compared DENV2 genome sequences from RNAseq data collected from biologically replicated triplicate samples of naive C6/36 and wMelPop-C6/36 cells infected with wild-type (WT) DENV2. A very low a Among 319 transcripts that were upregulated by DENV2 infection but downregulated by the presence of wMelpop (shown in Fig. 5 ). The six selected gene numbers (first column) and the LogFC of up-and downregulated transcripts (columns 4 and 5, respectively), involved in lipid and fatty acid metabolism, are shown in bold (see the text). AALF008690 is given the letter "a" because although 2.8 is below the cut-off of 3.0, Ϫ5.9 is significant.
frequency of mutations was observed in the DENV2 genome after infection of naive C6/36 cells (Table 3 ). In naive C6/36 cells, one mutation was observed within the NS2B gene (Ile22Thr; 9.9 to 10.2%) in all triplicates and a second mutation was found within the 3= UTR (10607, A to C; 11.5%) in one of the triplicates (Table 3 ). In contrast, the DENV2 RNAs from wMelPop-C6/36 cells exhibited abundant mutations (43 to 64 locations) distributed mostly in the E protein, especially within an 11-amino-acid region between Met455 and Trp465 (22 to 31 residues [ Fig. 6 and Table 4 ]). Moreover, we found that the highest rates of amino acid replacements (Ͼ97%) were localized at 7 positions in the envelope (Glu202Gly), NS2A (Leu201Phe), NS2B (Thr94Ile, Thr101IIe, and Ile114Thr), NS4B (Tyr99Cys), and NS5POL (Leu716Val) (in bold in Table 4 ) and in all triplicate samples (Table 4 ). 
4472 (Ile22Thr, 9.9%) 4472 (Ile22Thr, 10.2%) 4472 (Ile22Thr, 9.9%) NS3pro
The cutoff for inclusion is Ͼ5% abundance. 1st, 2nd, and 3rd refer to biological replicates. The number refers to the nucleotide location (1 to 10723) in DENV2 RNA (New Guinea C strain) (51) . Location of amino acid change and its frequency of occurrence are shown within parentheses. Three-letter amino acid codes are used for dominant variant. ND, not detected.
The mutant DENV2 from wMelPop-C6/36 cells replicated less efficiently in naive C6/36 cells but with profound delay in BHK-21 and Vero cells. We tested if a mutant virus population recovered from wMelPop-C6/36 cells can infect and replicate in naive C6/36 cells as well as in mammalian cells such as BHK-21 cells and Vero cells.
As shown in Fig. 7A , WT DENV2 replicated and caused cytopathic effect (CPE) in BHK-21 cells in 1 day postinfection which progressed to significant cell death at 3 days postinfection. In Vero cells infected with WT DENV2, the replication was robust at day 1 postinfection, but the CPE was less than that observed in BHK-21 cells at day 3 postinfection (Fig. 7C) . In contrast, mutant DENV2 replicated poorly and showed no apparent CPE in BHK-21 cells (Fig. 7B) or Vero cells (Fig. 7D ). Moreover, similar to the failure in syncytium formation in wMelPop-C6/36 cells infected with WT DENV2 (Fig. 3A) , the naive C6/36 cells infected with the mutant DENV2 also failed to form syncytia, in contrast to those infected with WT DENV2 (data not shown). Next, the viral RNA copy numbers were determined by qRT-PCR to measure the replication efficiency of the mutant DENV2 in BHK-21 and Vero cells ( Fig. 7E and F) . We found that the mutant DENV2 replicated in naive C6/36 cells, albeit less efficiently (Fig. 7E ). However, the mutant DENV2 was significantly slower to replicate in either BHK-21 cells or Vero cells than was wild-type DENV2 (Fig. 7F ). Sequence analysis of the viral RNA recovered from BHK-21 cells further revealed that the mutated viral sequences were outnumbered by the reversions to wild-type sequences at 3 days postinfection ( Fig. 8A and B ). In addition, the mutant viral RNA acquired additional mutations in NS3 in both protease and helicase domains (Fig. 8C) . These results indicate that the mutant DENV2 that evolved in wMelPop-C6/36 cells was attenuated for replication in BHK-21 cells and reverted either partially or completely at some sites to wild-type sequences or acquired additional compensatory mutations in the NS3 gene which caused better replication fitness in BHK-21 cells. In contrast, the mutant DENV2 kept all mutations during replication in naive C6/36 cells (Fig. 8 ). 
Glu202Gly mutation at DENV2 envelope gene does not affect replication in C6/36 cells but is critical for replication in BHK-21 cells.
Next, we sought to confirm our observation that some of the dominant mutations do revert to WT in BHK-21 cells as shown in Fig. 8 . We focused on one dominant mutation that arose in the envelope gene after DENV2 infection of wMelPop-C6/36 cells. We engineered the Glu202Gly mutation into WT DENV2 as described in Materials and Methods (45, 51) . We transfected the Glu202Gly mutant viral RNA into BHK-21 and C6/36 cells and monitored the viral replication by immunofluorescence assay (IFA) using anti-NS1 antibody. As shown in Fig. 9 , the Glu202Gly mutant replicated well in both BHK-21 and C6/36 cells ( Fig. 9A  and B ) without any CPE to BHK-21 cells. In contrast, WT RNA caused robust CPE at 7 days postelectroporation ( Fig. 9A, right top) .
Sequence analysis of viral RNA extracted from the supernatants from the Glu202Gly mutant-transfected cells showed that this Glu202Gly mutant viral RNA species dimin- ished over time with the concomitant appearance of the WT Glu202 as the majority species at 11 days postelectroporation in BHK-21 cells. In contrast, the Glu202Gly mutant stayed as the majority species at 11 days and no reversion to WT virus detected in naive C6/36 cells (Fig. 9C) . The mutant-transfected cells also retained the ability to form syncytia (data not shown). These results clearly showed that Glu202Gly mutation at the DENV2 envelope gene is critical for replication in BHK-21 cells, although this mutation does not affect viral replication or syncytium formation in C6/36 cells.
DISCUSSION
Aedes aegypti and Aedes albopictus mosquitoes are important vectors for DENV, YFV, Chikungunya virus, and Zika virus transmission and are of increasing public health concern. Previous studies have shown that infection of both A. aegypti and A. albopictus by the wMelPop strain of Wolbachia makes these mosquito vectors refractory to transmission of several flaviviruses, including DENV (52) (53) (54) (55) . Furthermore, because wMelPop infections can spread rapidly through natural populations, it is possible that release of wMelPop-infected adult mosquitoes into uninfected populations could provide a novel approach to suppress DENV transmission in areas where DENV is endemic (53, 54, 56) .
In a recent study, it was shown that DENV replication in all four serotypes is reduced in A. aegypti (Aad2) cells infected with the Wolbachia Mel strain (Aad2-wMel). The reduction in replication was associated with enhanced degradation of viral RNA by cellular exonuclease, XRN1 (57) . However, there are likely additional effects of the symbiont on the mosquito host vector, especially on virus replication, infectivity, and transmission, which had not been previously investigated.
Analysis of cellular transcripts by RNAseq showed that many genes upregulated in response to DENV2 infection in naive C6/36 cells were downregulated in response to DENV2 infection in the presence of wMelPop (Fig. 5) . We focused on a group of genes involved in lipid and fatty acid metabolism (Table 2 ) because of previous evidence indicating that the DENV-blocking effect of Wolbachia is, at least in part, due to a disruption of lipid and fatty acid metabolism that is required for the viral life cycle, especially in viral replication and assembly of virus particles (46) (47) (48) (49) . Several genes that have previously been shown to be dysregulated in the tissues or cells of Aedes mosquitoes in response to DENV infection exhibited reversed expression patterns in response to DENV infection in wMelPop-C6/36 cells relative to naive C6/36 cells. For example, fatty acid synthase gene expression was reported to be upregulated in DENV-infected human Huh7.5 cells (58) as well as mosquito cells (49) . We found two fatty acid synthase genes (AALF013575 and AALF025833) that were also upregulated in naive C6/36 cells in response to DENV infection but were downregulated in wMelPop-C6/36 cells infected with DENV2 ( Table 2 ). DENV NS3 protein recruits fatty acid synthase to sites of viral replication in the ER (58) . In addition, we found that sterol CoA desaturase (AALF008690) was 2.8-fold upregulated by DENV2 infection of naive C6/36 cells but was 5.9-fold downregulated in the presence of wMelPop infection ( Table 2) . This enzyme is involved in biosynthesis of monounsaturated fatty acids and was shown in a recent study to play a crucial role in DENV replication and virus release in human Huh7 cells (50) . Reduced levels of this protein in DENV2-infected wMelPop-C6/36 cells may cause the loss of virus infectivity, as we have shown by plaque assay in mammalian cells.
We found that infection of wMelPop-C6/36 cells with DENV2 profoundly impacted viral RNA by introducing mutations throughout the genome with different (ϳ5% to 97%) frequencies (Table 4) . Notably, many of these mutations are broadly distributed in E, NS2A, NS2B, NS3, NS4A, NS4B, and NS5 with ϳ25% to 95% frequency in triplicate biologically replicated samples. The mutant DENV2 recovered from wMelPop-C6/36 was able to infect and replicate in naive C6/36 cells with slightly reduced efficiency, but it was unable to replicate efficiently in BHK-21 and Vero cells, although there was a lack of antiviral type I interferon (IFN) response in these mammalian cells (59) (60) (61) .
Type I IFNs are important mediators of innate immune responses for protecting the host against viral infections. DENVs have evolved mechanisms to counteract the antiviral response of type I IFNs predominantly due to NS4B and, to a lesser extent, NS2A and NS4A (62, 63) . DENV2 NS5 is also involved in evading innate immune response by targeting STAT2 via a proteasome-mediated degradative pathway (64) (65) (66) (67) . Previous studies showed that when human hepatoma cells were pretreated with IFN-alpha/beta and infected with DENV2, the viral RNA was reduced Ͼ1,000-fold and infectious particles Ͼ100,000-fold (68, 69) . In humans, in the dendritic cells (DCs), the primary target of DENV (70) , inhibition of the type I IFN response requires catalytically active NS2B-NS3 protease (71) , which cleaves human STING (72) . Interestingly, the NS4B Y99C mutation is located in the region from amino acid residues 77 to 125, which was previously shown to be required for inhibition of IFN-alpha/beta signaling (63) . The mechanism of how these multiple and broad-range mutations in DENV2 occurred is not known. It is possible that the competition for limited cellular factors and nucleotide pool in wMelPop-C6/36 cells may have resulted in loss of fidelity of RNAdependent RNA polymerase for viral replication (73) . In this regard, it is noteworthy that a single dominant mutation (Leu716Val) occurred with Ͼ97% frequency in the NS5 polymerase domain. The impact of this mutation in fidelity of viral replication remains to be investigated.
The accumulated mutations of E (Met455-Trp465) in the region of TMD1 of E protein (16 amino acids between Ser452 and Gly467) may be responsible for the defect in virus assembly. The length and the amino acid residues in the TMD of DENV E protein are critical for assembly in the ER (28) and are likely involved in the kinetics of E protein trafficking from the ER to the Golgi apparatus (GA) (74, 75) . Other TMDs in NS2A, NS2B, NS4A, and NS4B could be involved in anchoring the viral replication complex to the ER membrane. The fact that nearly complete amino acid changes (Ͼ97%) in NS2A, NS2B, and NS4B are localized at or near the TMDs (Fig. 10) , is consistent with the hypothesis that wMelPop affects the structure and function of the NS proteins involved in replication and assembly in the ER membrane.
Furthermore, altered NS3 sequences in the mutant DENV2 emerged from BHK-21 cells could be the result of compensatory mutations for alterations of NS2B and NS4A, both of which are known to interact with NS3 (5) (6) (7) 22 ). An alternate possibility is that these NS3 mutations are involved in regulation of functions independent of protease in processing but are likely involved in replication and/or assembly (10, 22, (76) (77) (78) (79) (80) . Further work is necessary to dissect the functional significance of the DENV mutations induced by wMelPop in C6/36 and mammalian cells. Detailed analysis of these wMelPop-mediated virus-mosquito host response genes is likely to provide a wealth of new information relevant to suppression of DENV transmission by Aedes mosquitoes.
MATERIALS AND METHODS
Cell culture and virus infections.
A. albopictus (C6/36) cells were obtained from the American Type Culture Collection (ATCC), and low-passage stocks were made and frozen in liquid nitrogen. C6/36 cells were grown in minimum essential medium (MEM) containing 5% fetal bovine serum (FBS), 2 mM L-glutamine, 25 mM HEPES (pH 7.2), 1 mM sodium pyruvate, 1ϫ nonessential amino acids, 100 U/ml of penicillin, and 100 g/ml of streptomycin at 28°C. C6/36 cells, in which the endosymbiont wMelPop stably replicates (referred to here as wMelPop-C6/36 cells), were grown in the same medium and under the same conditions as described above. The naive C6/36 cells and wMelPop-C6/36 cells were authenticated by PCR. Briefly, cellular DNAs from both cell types were extracted using the following method. After the cells were washed with ice-cold phosphate-buffered saline (PBS), the samples were digested with 0.3 ml (for ϳ3 ϫ 10 7 cells) of a buffer containing 100 mM NaCl, 10 mM Tris-HCl (pH 8.0), 25 mM EDTA (pH 8.0), 0.5% (wt/vol) SDS, and 0.1 mg/ml of proteinase K, followed by phenol-chloroform-isoamyl alcohol extraction and ethanol precipitation as described previously (81) . wMelPop infection of C6/36 cells was confirmed by PCR using the extracted DNA from wMelPop-C6/36 cells, compared with that from naive C6/36 cells. The primers used were specific for A. albopictus ND5: ND5 forward, 5=-TATCTACATTA AGTCAATTAGG, and ND5 reverse, 5=-CAAGTTAAAGGTATTCTTATTC. The PCR product's size was 199 bp. For verification of the presence of the symbiont in wMel-Pop-C6/36 cells, the PCR primers used were specific for wMelPop IS5 gene, and the PCR product size was 201 bp. The PCR primers were the following: IS5 forward, 5=-GAAGCAATTTTCTATGTATTGCG, and IS5 reverse, 5=-ACTATCTACTATACAGGCACTCG. PCR was performed with 35 cycles (denaturation at 95°C for 10 s, annealing at 50°C for 10 s, and extension at 72°C for 20 s) ( Fig. 2) . BHK-21 cells and Vero cells were obtained from the ATCC. Low-passage stocks were made and were frozen in liquid nitrogen. Cells were grown in MEM containing 2 mM L-glutamine, 100 U/ml of penicillin, and 100 g/ml of streptomycin (maintenance medium) and 5% FBS at 37°C in a 5% CO 2 incubator. DENV2 (New Guinea C strain) was given as a gift by Robert Putnak, Walter Reed Army Institute of Research, Washington, DC. DENV2 stocks were prepared by infection of C6/36 cells, and the virus titers (ϳ10 6 PFU/ml) were measured by plaque assays using LLC/MK2 cells as previously described (45) . Naive C6/36 and wMelPop-C6/36 cells were infected with DENV2 in triplicate T-75 flasks. DENV2 stock was diluted in 2% FBS supplemented with maintenance medium and added to 70% confluent monolayer cells at an MOI of 1. Cells were incubated for an hour at room temperature. Then, the culture media were replaced with maintenance medium containing 5% FBS and the cells were incubated in a humidified chamber at 28°C. After 3 to 5 days postinfection, culture supernatants were collected after centrifugation at 3,000 rpm for 5 min. Monolayer cells were used for RNA extraction.
RNA extractions and qRT-PCR. Viral RNAs from supernatants of infected C6/36 cells were extracted using a ZR viral RNA kit (Zymo Research) according to the manufacturer's instructions. Synthesis of cDNAs by reverse transcriptase (RT) were performed by incubation of RNAs with Moloney murine leukemia virus (M-MuLV) RT, random primers, and deoxynucleoside triphosphates (dNTPs) (New England Biolabs) at 42°C for 2 h. To quantify DENV2 RNA copy number, quantitative RT-PCR (qRT-PCR) was performed in duplicate using iTaq Universal SYBR green Supermix (Bio-Rad), as described previously (82) . The average threshold cycle (C T ) values were converted to viral copy numbers by comparing with the standard plot established from known amounts of DENV2 cDNA. RNAs from monolayer of C6/36 cells were extracted with TRIzol (Ambion Life Technologies) according to the manufacturer's instructions. RNA quantity and integrity were determined on an Agilent 2100 Bioanalyzer.
cDNA library preparation and RNAseq analysis. RNAseq was performed on three biological replicates of each of the following four experimental treatments: (i) naive C6/36 cells, (ii) naive C6/36 cells infected with DENV2, (iii) wMelpop-C6/36 cells, and (iv) wMelpop-C6/36 infected with DENV2. Illumina paired-end mRNA-Seq library construction was performed by the Institute for Genome Sciences at the University of Maryland. One RNA sample (C6/36_wMelPop_1 [ Table 1 ]) failed the initial quality control step and so was not included in subsequent analyses. The remaining 11 samples were treated with Bacterial Ribo-Zero (Illumina) and human/mouse/rat Ribo-Zero (Illumina) to remove rRNA. Sequencing libraries were prepared without poly(A) enrichment according to the TruSeq RNA sample preparation kit (version 2; Illumina). The 11 libraries were individually barcoded (83) according to Illumina's instructions and equally split for paired-end sequencing on two flow cell lanes of an Illumina HiSeq 4000 sequencer (average insert size ϭ 252 bp; read length ϭ 151 bp). One library (IL100072642_L003 [Table 1 ]) was sequenced again on a separate portion of a lane to increase the number of reads.
Read cleaning. Raw reads were first screened using ssaha2 (84) and the UniVec database (accessed 7 July 2013) to remove vector sequences, adapters, linkers, and primers commonly used in cloning cDNA or genomic DNA as well as A. albopictus rRNA sequences (GenBank accession no. L22060.1). The cutoff for sequence removal was 95% identity and an alignment score of 18. In addition, Illumina sequencing multiplex adapters were identified using ssaha2, with 100% identity and an alignment score of 18 as the cutoff for removal. In all cases, contaminated reads were removed along with their read mates in a pair. After ssaha2 screening, cleaned reads were further filtered using SolexaQA version 2.2 to retain contiguous reads longer than 50 bp with phred quality scores higher than 30. Read cleaning results are presented in Table 1 .
